Second judge says US not liable in Moderna COVID-19 vaccine patent case
By Blake Brittain (Reuters) - Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability to the U.S. government for paten...
Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Blake Brittain (Reuters) - Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability to the U.S. government for paten...
Moderna failed to persuade a Delaware federal judge on Wednesday to shift liability from the company to the US government for alleged patent infringement by Moderna's COVID-19 vaccine.
Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability to the U.S. government for patent infringement allegations based on COVID-19 vaccines it provided for the... | April 26, 2023
Abdera Therapeutics emerged from stealth with technology that improves the way antibodies deliver radiopharmaceuticals for cancer. A lead program with preclinical proof-of-concept data in small cell lung cancer is on track to reach the clinic in 2024.
Last week, Arbutus Biopharma Corp. and Genevant Sciences GmbH (collectively, Arbutus) filed a complaint for patent infringement in the District of New Jersey against Pfizer, Inc. and BioNTech SE.